• Home
  • Stock
  • Mankind Pharma Fundamental Analysis
  • Mankind Pharma Fundamental Analysis

Mankind Pharma fundamental analysis

MANKIND

HealthcareLarge

2210

4.40 (0.20%)
Last updated on 4 Dec, 2025 | 14:18 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Mankind Pharma Fundamentals

P/E Ratio

52.01

P/B Ratio

5.96

Div. Yield

0

Sector P/E

36.44

Sector P/B

0.91

Sec. Div. Yield

0.56

  • Mankind Pharma Fundamentals is currently trading with a P/E Ratio of 52.01, compared to the sector average of 36.44. Its P/B Ratio stands at 5.96, while the sector’s is 0.91. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Mankind Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Mankind Pharma reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.